Menu
Recruiting NCT06997549

Retrospective Analyses of the Greenbrook Database Evaluating Mental Health Treatments

— Observational Depression OCD Anxiety Depression

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Patients treated with NeuroStar TMS, Patients treated with Esketamine.
Who it may be relevant to
Registry conditions: Depression, OCD, Anxiety Depression. Basic parameters: 5 years — 100 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

The study involves multiple retrospective analyses to understand the utilization of mental health treatments provided at Greenbrook and their effectiveness

Detailed description

this is a retrospective data analysis study that will utilize the already collected data as clinical care and will help understand the utilization and efficacy of various treatment options available for various mental heath conditions.

Interventions

  • Device Patients treated with NeuroStar TMS
    non-invasive brain stimulation device
  • Drug Patients treated with Esketamine
    nasal spray for treating depression

Primary outcome measures

  • change in clinical outcome scores from baseline to post treatment [Time frame: 8 weeks]

Eligibility criteria

Inclusion criteria

  • Male or female reported in database and not an invalid entry
  • Age reported and not an invalid entry
  • Treatment date in 2011 or later.

Exclusion criteria

  • Incomplete information on treatment parameters

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

United States · 1 center
  • Neuronetics — Malvern

Identifiers

NCT: NCT06997549 · 11-10002-000

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗